EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid-based nanoparticles as drug delivery carriers for cancer therapy

Ibtesam Waheed, Anwar Ali, Huma Tabassum, Narjis Khatoon, Wing-Fu Lai, Xin Zhou

Frontiers in Oncology · 10.04.2024 · 14

DOI: 10.3389/fonc.2024.1296091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 10.04.2024. Verfasst von Ibtesam Waheed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China. Die Arbeit wurde bisher 178-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a severe disease that results in death in all countries of the world. A nano-based drug delivery approach is the best alternative, directly targeting cancer tumor cells with improved drug cellular uptake. Different types of nanoparticle-based drug carriers are advanced for the treatment of cancer, and to increase the therapeutic effectiveness and safety of cancer therapy, many substances have been looked into as drug carriers. Lipid-based nanoparticles (LBNPs) have significantly attracted interest recently. These natural biomolecules that alternate to other polymers are frequently recycled in medicine due to their amphipathic properties. Lipid nanoparticles typically provide a variety of benefits, including biocompatibility and biodegradability. This review covers different classes of LBNPs, including their characterization and different synthesis technologies. This review discusses the most significant advancements in lipid nanoparticle technology and their use in medicine administration. Moreover, the review also emphasized the applications of lipid nanoparticles that are used in different cancer treatment types.

Schlagwörter

Stichwörter der Autor:innen

active targetingcancer therapydrug deliverylipid-based nanoparticlesnanomedicinepassive targeting

Autor:innen und Institutionen

  • Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
  • Department of Applied Biology and Chemical Technology, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
  • Department of Biochemical and Biotechnological Sciences, School of Precision Medicine, University of Campania, Naples, Italy.
  • Institute of Social and Cultural Studies, Department of Public Health, University of the Punjab, Lahore, Pakistan.
  • Department of Biotechnology, Lahore College for Women University, Lahore, Pakistan.
  • School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom.

Zitieren

APA

Waheed, I., Ali, A., Tabassum, H., Khatoon, N., Lai, W. F., & Zhou, X. (2024). Lipid-based nanoparticles as drug delivery carriers for cancer therapy. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1296091

Vancouver

Waheed I, Ali A, Tabassum H, Khatoon N, Lai WF, Zhou X. Lipid-based nanoparticles as drug delivery carriers for cancer therapy. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1296091

BibTeX
@article{Waheed2024,
  author = {Waheed, Ibtesam and Ali, Anwar and Tabassum, Huma and Khatoon, Narjis and Lai, Wing-Fu and Zhou, Xin},
  title = {Lipid-based nanoparticles as drug delivery carriers for cancer therapy},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1296091}
}
Kostenlos starten →